Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens-Reference-Cited by-同舟云学术

Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens

Published:2023 Issue:21 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Park Hae-Young¹^ORCID,Kwon Jin-Won¹^ORCID,Kim Hye-Lin²^ORCID,Kwon Sun-Hong³^ORCID,Nam Jin Hyun⁴^ORCID,Min Serim³^ORCID,Oh In-Sun³⁵⁶^ORCID,Bea Sungho³^ORCID,Choi Sun Ha⁷^ORCID

Affiliation:

1. BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea.

2. College of Pharmacy, Sahmyook University, Seoul, Korea.

3. School of Pharmacy, Sungkyunkwan University, Suwon, Korea.

4. Division of Big Data Science, Korea University Sejong Campus, Sejong, Korea.

5. Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea.

6. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.

7. Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e167

Reference27 articles.

1. World Health Organization. Global tuberculosis report 2021. Accessed in March 28, 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globaltuberculosis-report-2021

2. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: Treatment – drug-resistant tuberculosis treatment. Updated 2021. Accessed March 28, 2022. https://www.who.int/publications/i/item/9789240007048

3. Korea Disease Control and Prevention Agency. Infectious disease portal, 2021. Tuberculosis notification annual report. Accessed March 28, 2022. https://www.kdca.go.kr/npt/biz/npp/portal/nppPblctDtaView.do?pblctDtaSeAt=1&pblctDtaSn=2333

4. Tuberculosis control in the Republic of Korea

5. Effect of COVID-19 on Tuberculosis Notification, South Korea